chrX-64917843-A-T
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1
The NM_001178033.3(ZC4H2):c.452T>A(p.Phe151Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0154 in 1,208,636 control chromosomes in the GnomAD database, including 1,907 homozygotes. There are 4,972 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 10/12 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001178033.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZC4H2 | NM_018684.4 | c.615T>A | p.Leu205Leu | synonymous_variant | 5/5 | ENST00000374839.8 | NP_061154.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZC4H2 | ENST00000374839.8 | c.615T>A | p.Leu205Leu | synonymous_variant | 5/5 | 1 | NM_018684.4 | ENSP00000363972.3 |
Frequencies
GnomAD3 genomes AF: 0.0822 AC: 9117AN: 110934Hom.: 1030 Cov.: 22 AF XY: 0.0710 AC XY: 2356AN XY: 33180
GnomAD3 exomes AF: 0.0239 AC: 4339AN: 181710Hom.: 447 AF XY: 0.0154 AC XY: 1020AN XY: 66258
GnomAD4 exome AF: 0.00866 AC: 9501AN: 1097648Hom.: 878 Cov.: 30 AF XY: 0.00716 AC XY: 2601AN XY: 363028
GnomAD4 genome AF: 0.0822 AC: 9128AN: 110988Hom.: 1029 Cov.: 22 AF XY: 0.0713 AC XY: 2371AN XY: 33244
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 26, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 15, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at